AAN 2026 — American Academy of Neurology Annual Meeting
active
wiki pageCreated: 2026-04-02T07:20:05By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-events-aan-2026
📖 Wiki Page
event756 wordssynced 2026-04-02
Dates: April 18-22, 2026
Location: McCormick Place, Chicago, Illinois, USA
Organizer: American Academy of Neurology
Website: [aanannualmeeting.com](https://www.aan.com/annualmeeting)
Dates: April 18-22, 2026
Location: McCormick Place, Chicago, Illinois, USA
Organizer: American Academy of Neurology
Website: [aanannualmeeting.com](https://www.aan.com/annualmeeting)
Overview
Mermaid diagram (expand to render)
AAN 2026 will be held in Los Angeles, continuing the tradition of the world's largest neurology conference. The meeting will feature the latest advances in neurological research and clinical practice, bringing together over 12,000 neurologists, neuroscientists, and neurology trainees from around the world["@aan"].
The American Academy of Neurology's Annual Meeting is the premier event for the neurology community, showcasing groundbreaking research across all subspecialties of neurology. AAN 2026 will emphasize precision medicine, biomarkers, and novel therapeutic approaches for neurological disorders["@american"].
Conference Highlights
Key Dates
November 2025: Abstract submission opens
February 2026: Early registration deadline
April 18-22, 2026: Main conference
April 16, 2026: Post-conference workshops
Expected Attendance
Over 12,000 in-person attendees
More than 3,000 scientific abstracts
Over 200 educational sessions
Representatives from 100+ countries
Session Types
Plenary Sessions: Keynote addresses from leading researchers
Scientific Sessions: Platform presentations of original research
Poster Sessions: Visual presentations of ongoing research
Workshops: Hands-on clinical skill building
Courses: Didactic teaching sessions
Late-Breaking Science: Results from recently completed trials
Key Research Themes
1. Neurodegeneration
The neurodegeneration track will feature significant advances in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other progressive neurological conditions:
Alzheimer's Disease and Related Dementias
Blood-based biomarkers: Clinical implementation of [p-tau217](/biomarkers/p-tau-217), p-tau181, andNfL
Anti-amyloid therapies: Updates on [lecanemab](/entities/lecanemab), [donanemab](/entities/donanemab), and next-generation antibodies
Anti-[tau](/proteins/tau) therapies: Results from Phase 2 and 3 trials
Precision medicine: Genetic and biomarker-guided treatment approaches
Prevention trials: Updates from the A4, DIAN, and API trials
Parkinson's Disease and Movement Disorders
[Alpha-synuclein](/proteins/alpha-synuclein) targeting: Immunotherapies and small molecules
DBS advances: Directional leads and closed-loop systems
Gene therapy: Results from ongoing trials
Neuroprotection: Disease-modifying strategies
Non-motor symptoms: Sleep, autonomic dysfunction, and cognition
2. Cerebrovascular Disease
Stroke prevention: Anticoagulation and antiplatelet strategies
Acute stroke treatment: Thrombolysis and thrombectomy updates
Vascular cognitive impairment: Mechanisms and prevention
Small vessel disease: MRI biomarkers and treatment targets
3. Epilepsy
Novel antiseizure medications
Surgical treatment advances
SUDEP risk reduction
Genetics and precision medicine
Device-based therapies (RNS, VNS)
4. Multiple Sclerosis
B-cell and T-cell therapies
Progressive MS treatments
Remyelination strategies
Biomarkers of treatment response
5. Neuromuscular Disorders
Genetic therapies for SMA and Duchenne
Amyotrophic lateral sclerosis trials
Myasthenia gravis biologics
Peripheral neuropathy treatments
6. Headache and Pain
CGRP and related targeted therapies
Neuromodulation devices
Chronic migraine prevention
Post-herpetic neuralgia
Education and Professional Development
Career Development
Early Career Neurology Session
Mentorship programs
Research funding workshops
Practice management courses
Clinical Skills
Hands-on workshops
Simulation training
Case-based learning
Board review courses
Venue: Los Angeles
Los Angeles Convention Center
Located in downtown Los Angeles, the LACC offers:
State-of-the-art presentation facilities
Multiple exhibit halls
Proximity to hotels and restaurants
Easy access from LAX airport
About Los Angeles
Los Angeles is home to:
University of California Los Angeles (UCLA) Neurology
University of Southern California (USC) Neurology
Cedars-Sinai Medical Center
Multiple VA healthcare facilities
Thriving biotech and pharmaceutical industry
Notable Expected Presentations
While specific programs are released closer to the conference, AAN 2026 is expected to feature:
Presidential Plenary
President's Lecture on the future of neurology
Distinguished Teacher Award Lecture
A.B. Baker Award for Neurology Education
Late-Breaking Science
Clinical trial results in Alzheimer's disease
Parkinson's disease treatment advances
Stroke prevention studies
Novel therapeutic approaches
Special Sessions
Diversity and inclusion in neurology
Global neurology initiatives
Climate and neurological health
AI in neurological practice
Registration and Travel
Registration Categories
Member (MD/PhD)
Non-member
Resident/Fellow
Medical Student
Allied Health Professional
Virtual access
Travel Information
Major airports: LAX, Burbank, Long Beach
Hotel discounts available
Visa assistance for international attendees
Related Conferences
[AAIC 2026](/events/aaic-2026) — Alzheimer's Association International Conference](/events)
[MDS 2026](/events/mds-2026) — Movement Disorder Society](/events)